Novel Combined Contraceptive Estelle Among Nine New Filings At EMA
Executive Summary
Mithra says its new oral contraceptive could be a major breakthrough in a “space where there hasn’t been any innovation in decades."
You may also be interested in...
Regulators Decide On EU Marketing For 'Game-Changing' Contraceptive
Mithra’s combined oral contraceptive Estelle includes estetrol, the first compound in the contraceptive area to be designated a new active substance in Europe in over 80 years.
New Filings At The EMA
New medicines under evaluation at the European Medicines Agency.
New Filings At The EMA
New medicines under evaluation at the European Medicines Agency.